OSTEOVANCE Trademark

Trademark Overview

On Thursday, November 24, 2016, a trademark application was filed for OSTEOVANCE with the United States Patent and Trademark Office. The USPTO has given the OSTEOVANCE trademark a serial number of 79207047. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 12, 2024. This trademark is owned by Australian Biotechnologies Pty Limited. The OSTEOVANCE trademark is filed in the Pharmaceutical Products category with the following description:

biological tissue cultures for medical purposes; guided tissue regeneration materials, namely, biological tissue grafts, implant materials for use in guided tissue regeneration, namely, biological tissue grafts; implantable textile material to encourage the growth of tissue, namely, biological tissue grafts comprised primarily of living tissue; implants for guided tissue regeneration, namely, biological tissue grafts; surgical grafts comprising living biological tissues; surgical implants comprised of living tissues; surgical implants comprised of living tissues grown from stem cells; transplants comprised of living tissues, namely, implants comprising living tissue, biological tissue grafts; allograft implants being materials in the nature of human allograft tissue for use in guided tissue regeneration
osteovance

General Information

Serial Number79207047
Word MarkOSTEOVANCE
Filing DateThursday, November 24, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 12, 2024
Registration Number5362094
Registration DateTuesday, December 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and Servicesbiological tissue cultures for medical purposes; guided tissue regeneration materials, namely, biological tissue grafts, implant materials for use in guided tissue regeneration, namely, biological tissue grafts; implantable textile material to encourage the growth of tissue, namely, biological tissue grafts comprised primarily of living tissue; implants for guided tissue regeneration, namely, biological tissue grafts; surgical grafts comprising living biological tissues; surgical implants comprised of living tissues; surgical implants comprised of living tissues grown from stem cells; transplants comprised of living tissues, namely, implants comprising living tissue, biological tissue grafts; allograft implants being materials in the nature of human allograft tissue for use in guided tissue regeneration
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAustralian Biotechnologies Pty Limited
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU
Party NameAustralian Biotechnologies Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU
Party NameAustralian Biotechnologies Pty Limited
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events

Event DateEvent Description
Friday, May 12, 2017ASSIGNED TO EXAMINER
Thursday, May 11, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2017REFUSAL PROCESSED BY MPU
Tuesday, May 16, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, May 16, 2017NON-FINAL ACTION WRITTEN
Wednesday, May 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 2, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 24, 2017REFUSAL PROCESSED BY IB
Monday, July 31, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 22, 2017ASSIGNED TO LIE
Thursday, August 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 24, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 22, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 22, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 4, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 4, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 18, 2017ASSIGNED TO PETITION STAFF
Friday, October 6, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 20, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Saturday, October 21, 2017NOTIFICATION PROCESSED BY IB
Tuesday, December 26, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 26, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 5, 2018FINAL DISPOSITION PROCESSED
Thursday, April 5, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 19, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 26, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sunday, March 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2024CANCELLED SECTION 71

Related Keywords

osteovance tissue biological grafts living namely implants comprised tissues regeneration guided